Hydroxyethyl starches: A tale of two contexts: The problem of knowledge

Anesthesia and Analgesia

Volumn 119, Issue 3, 2014, Pages 509-513

  Weiskopf, Richard B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH;

CLINICAL PRACTICE; COLLOID; CRITICALLY ILL PATIENT; CRYSTALLOID; DRUG INDICATION; DRUG SAFETY; HUMAN; KIDNEY INJURY; MORTALITY; PRIORITY JOURNAL; REVIEW;

BLOOD VOLUME; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; HYPOVOLEMIA; INTENSIVE CARE; PLASMA SUBSTITUTES;

EID: 84906688341     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000000323     Document Type: Review

References (27)

1. Irwin MG, Gan TJ. Volume therapy with hydroxyethyl starches: Are we throwing the anesthesia baby out with the intensive care unit bathwater? Anesth Analg 2014;119:737-9
2. Raghunathan K, Miller TE, Shaw AD. Intravenous starches: Is suspension the best solution? Anesth Analg 2014;119:731-6
3. Shafer SL. Notice of retraction. Anesth Analg 2010;111:1567
4. Shafer SL. Editor's note: Notices of retraction. Anesth Analg 2011;112:1246-7
5. Shafer SL. Shadow of doubt. Anesth Analg 2011;112:498-500
6. Weiskopf RB. Equivalent efficacy of hydroxyethyl starch 130/0.4 and human serum albumin: If nothing is the same, is everything different? The importance of context in clinical trials and statistics. Anesthesiology 2013;119:1249-54
7. Annane D, Siami S, Jaber S, Martin C, Elatrous S, Declere AD, Preiser JC, Outin H, Troche G, Charpentier C, Trouillet JL, Kimmoun A, Forceville X, Darmon M, Lesur O, Regnier J, Abroug F, Berger P, Clec'h C, Cousson J, Thibault L, Chevret S. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: The CRISTAL randomized trial. JAMA 2013;310:1809-17
8. Jungheinrich C, Neff TA. Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 2005;44:681-99
9. Waitzinger J, Bepperling F, Pabst G, Opitz J. Hydroxyethyl starch (HES) [130/0.4], a new HES specification: Pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers. Drugs R D 2003;4:149-57
10. Lehmann GB, Asskali F, Boll M, Burmeister MA, Marx G, Hilgers R, Förster H. HES 130/0.42 shows less alteration of pharmacokinetics than HES 200/0.5 when dosed repeatedly. Br J Anaesth 2007;98:635-44
11. Leuschner J, Opitz J, Winkler A, Scharpf R, Bepperling F. Tissue storage of 14C-labelled hydroxyethyl starch (HES) 130/0.4 and HES 200/0.5 after repeated intravenous administration to rats. Drugs R D 2003;4:331-8
12. Kozek-Langenecker SA, Jungheinrich C, Sauermann W, Van der Linden P. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: A pooled analysis of randomized clinical trials. Anesth Analg 2008;107:382-90
13. Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005;103:654-60
14. Gandhi SD, Weiskopf RB, Jungheinrich C, Koorn R, Miller D, Shangraw RE, Prough DS, Baus D, Bepperling F, Warltier DC. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch. Anesthesiology 2007;106:1120-7
15. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, Madsen KR, Møller MH, Elkjar JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjaldgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J; 6S Trial Group; Scandinavian Critical Care Trials Group. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012;367:124-34
16. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA; CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012;367:1901-11
17. Wataha K, Menge T, Deng X, Shah A, Bode A, Holcomb JB, Potter D, Kozar R, Spinella PC, Pati S. Spray-dried plasma and fresh frozen plasma modulate permeability and inflammation in vitro in vascular endothelial cells. Transfusion 2013;53 Suppl 1:80S-90S
18. Torres LN, Sondeen JL, Ji L, Dubick MA, Torres Filho I. Evaluation of resuscitation fluids on endothelial glycocalyx, venular blood flow, and coagulation function after hemorrhagic shock in rats. J Trauma Acute Care Surg 2013;75:759-66
19. Zarychanski R, Abou-Setta AM, Turgeon AF, Houston BL, McIntyre L, Marshall JC, Fergusson DA. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: A systematic review and meta-Analysis. JAMA 2013;309:678-88
20. Van Der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesth Analg 2013;116:35-48
21. Martin C, Jacob M, Vicaut E, Guidet B, Van Aken H, Kurz A. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology 2013;118:387-94
22. Gillies MA, Habicher M, Jhanji S, Sander M, Mythen M, Hamilton M, Pearse RM. Incidence of postoperative death and acute kidney injury associated with i.v. 6% hydroxyethyl starch use: Systematic review and meta-Analysis. Br J Anaesth 2014;112:25-34
23. Bruegger D, Schwartz L, Chappell D, Jacob M, Rehm M, Vogeser M, Christ F, Reichart B, Becker BF. Release of atrial natriuretic peptide precedes shedding of the endothelial glycocalyx equally in patients undergoing on-And off-pump coronary artery bypass surgery. Basic Res Cardiol 2011;106:1111-21
24. European Medicines Agency. Hydroxyethyl Starch Solutions for Infusion. 2014. Available at: Http://www.ema.europa.eu/ ema/index.jsp?curl=pages/ medicines/human/referrals/ Hydroxyethyl-starch-containing-solutions/human- referral-prac-000012.jsp&mid=WC0b01ac05805c516f. Accessed March 18, 2014
25. FDA. FDA Safety Communication: Boxed Warning on Increased Mortality and Severe Renal Injury, and Additional Warning on Risk of Bleeding, for Use of Hydroxyethyl Starch Solutions in Some Settings. Revised 25 November 2013. 2013. Available at: Http://www.fda.gov/biologicsbloodvaccines/safetyavailability/ ucm358271.htm. Accessed March 18, 2014
26. Ayer AJ. The Problem of Knowledge. London: Macmillan, 1956
27. Jefferson T. First Inaugural Address. March 4, 1801.